ERIN WEINDORF: Open Payments
NPI 1932488764 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 35 payments from 13 companies in 2025. Trend: 2023 $840 · 2024 $612 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $184 |
| Novartis Pharmaceuticals Corporation | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Repatha, LEQVIO, FUROSCIX, ELIQUIS, LOKELMA, JARDIANCE, FARXIGA, VERQUVO.
Industry payments across PA — which companies pay providers there.
